Capillary Technologies India Limited has filed its quarterly compliance certificate under SEBI regulations for the quarter ended March 31, 2026. The technology company submitted the mandatory documentation to both BSE Limited and National Stock Exchange of India Limited on April 10, 2026, as part of its regulatory compliance obligations.

Regulatory Compliance Certificate Details

The certificate was issued pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. MUFG Intime India Private Limited, serving as the company's Registrar and Share Transfer Agent, provided the confirmation certificate dated April 9, 2026.

Share Holding Status Confirmation

MUFG Intime India Private Limited confirmed that during the quarter ended March 31, 2026, no demat requests were received for processing. This is attributed to the fact that all shares of Capillary Technologies India Limited are held in electronic mode only, eliminating the need for dematerialization processes.

The certificate was signed by Damodar Kambli, Assistant Vice President at MUFG Intime India Private Limited, formerly known as Link Intime India Private Limited. The RTA operates from its registered address at C-101, Embassy 247, L.B.S. Marg, Vikhroli (West), Mumbai.

Corporate Filing and Disclosure

Company Secretary and Compliance Officer Gireddy Bhargavi Reddy, with membership number A17091, digitally signed and submitted the compliance certificate from the company's Bengaluru office. The document was filed with both stock exchanges where the company is listed.

The company has made the certificate available on its official website under the investor relations section, specifically in the shareholder information and corporate announcements area. This ensures transparency and easy access for stakeholders seeking regulatory compliance information.

Capillary Technologies India Limited operates from its registered office at 360, bearing PID No: 101, 360, 15th Cross Rd, Sector 4, SR Layout, Bengaluru, Karnataka. The quarterly compliance filing demonstrates the company's adherence to SEBI regulations and maintains its good standing with regulatory authorities.

Capillary Technologies India Limited has announced a scheduled analyst and institutional investor meeting in compliance with regulatory requirements. The company filed the intimation on April 07, 2026, with both major stock exchanges.

Meeting Details and Schedule

The company has organized a virtual group meeting with analysts and institutional investors. The meeting details are structured as follows:

Regulatory Compliance and Disclosures

The announcement was made pursuant to Regulation 30 read with Para A of Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has provided this intimation to ensure transparency and regulatory compliance.

Capillary Technologies has made important clarifications regarding the meeting:

• The meeting schedule may undergo changes due to exigencies on the part of participants or the company
• No Unpublished Price Sensitive Information (UPSI) is intended to be discussed during the interaction
• The intimation has been placed on the company's official website for public access

Corporate Information

The intimation was signed by Gireddy Bhargavi Reddy, Company Secretary and Compliance Officer, with Membership No. A17091, from the company's Bengaluru office. The document was digitally signed on April 07, 2026, at 13:02:25 +05'30'.

Capillary Technologies India Limited operates with CIN L72200KA2012PLC063060 and maintains its registered office at 360, bearing PID No: 101, 360, 15th Cross Rd, Sector 4, SR Layout, Bengaluru, Karnataka 560102. The company provides stakeholder communication through its official website and designated email channels for secretarial matters.